|Articles|September 1, 2003

CXRs offer 'Limited Value' for Melanoma

Author(s)Beth Kapes

Chicago - A recent review of routine chest X-rays for pulmonary metastasis adds weight to a growing body of evidence that CXRs have limited value in the follow-up of melanoma patients and their prolonged survival.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Latest CME